Grifols Faces Investor Pressure Despite Improvements

Grifols, a Spanish pharmaceutical company, is experiencing pressure from short-selling investors, with the British hedge fund Kintbury Capital holding the largest short position in its history at 1.5% of the company's capital. This pressure comes despite recent improvements in the company's business performance.

Summarized from the sources above. Read the originals for the full story.